When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
As subscription fatigue grows, brands must rethink retention strategies beyond monthly billing. Here are a few innovative, value-driven ways to build loyalty and recurring engagement without locking customers into another subscription.
Most enterprise leaders have a licensing agreement. Almost none have a governance strategy. Here is the difference and why it is catching up with you faster than you think.
As subscription fatigue grows, brands must rethink retention strategies beyond monthly billing. Here are a few innovative, value-driven ways to build loyalty and recurring engagement without locking customers into another subscription.
As subscription fatigue grows, brands must rethink retention strategies beyond monthly billing. Here are a few innovative, value-driven ways to build loyalty and recurring engagement without locking customers into another subscription.